Custom firms cite the need for bigger toolboxes

The need for bigger toolboxes by the custom manufacturers to balance the requirement to invest capital in new technology with a need to turn a profit is discussed. It is expected that manufacturing market will grow to 130% over the next three years and expand to include emerging pharmaceutical and biotech companies as well as traditional major pharma customer base. It is believed that the custom manufacturing fine chemicals market will be dominated by those firms which have financial resources, good management and a mix of assets to serve both pharmaceutical and biotech firms. R&D excellence also needs to be fostered by customizing career advancement for scientists.